Dirk Thomas Waldschmidt, Nam Gyu Im, Alexander Damanakis, Thomas Schmidt, Albrecht Meyer zu Schwabedissen, Alexander Quaas, Linde Kehmann, Burkhard Deuß, Swantje Held, Christoph Roderburg, Sophia Chikhladze, Sören T. Mees, Jens Werner, Ulrich Ronellenfitsch, Georg Wiltberger, Rosa Klotz, Christoph Neumann-Haefelin, Christiane J. Bruns, Florian Gebauer. "First safety analysis of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with oxaliplatin and 5-fluoruracil/folinic acid followed by curative surgical resection in patients with hepatic oligometastatic adenocarcinoma of the pancreas (HOLIPANC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4172